US FDA signals a preference for nicotine pouches with new fast-track PMTA pilot

Nicotine pouches will be able to move more quickly through the US marketing authorisation process, following the launch of a pilot programme that acknowledges their place on the continuum of risk.

This move suggests the US is looking to embrace pouches as as its primary alternative nicotine product, in contrast to markets such as the UK. The UK’s scientific and regulatory consensus holds that e-cigarettes are the safest consumer nicotine product on the continuum of risk. UK guidance considers vaping less harmful than pouches or heated tobacco, although riskier than nicotine replacement therapies, like gums, patches and inhalers or pharmaceutical interventions.

Unlock access

Want the full analysis? Let's talk

We share insights with professionals we’re in contact with. Let us know a bit about your interest.

"*" indicates required fields

Facebook

This field is for validation purposes and should be left unchanged.

Corporate Email*

Company Name*

Name*

Department*

Industry*

Job title*

Company size*

Are you a decision-maker?*

Work Telephone*

How did you hear about us?*

How are you related to the industry?*

Tell us what you're interested in*

I'm already a subscriber

Freddie Dawson

Senior contributing editor

Freddie studied at King’s College, London and City University and worked for publications including The Times, The Malay Mail, PathfinderBuzz and Solar Summary before joining the TobaccoIntelligence team. He has extensive experience in covering fast-moving consumer goods (FMCG), manufacturing and technological innovation.

The global novel nicotine market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

TobaccoIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

Stay informed of any legal and market change in the sector that impacts your organisation
Maximise resources by getting market and legal data analysis daily in one place
Make smart decisions by understanding how the regulatory and market landscape evolves
Anticipate risks in your decisions by monitoring regulatory changes that impact your organisation

LATEST ALERTS

US FDA signals a preference for nicotine pouches with new fast-track PMTA pilot

Freddie Dawson

Our Key Benefits

Sign up to our newsletter